Stonebridge Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3
| Closed | -$588 | – | 350 |
|
|
2023
Q3 | $588 | Sell |
3
-23
| -88% | -$4.51K | ﹤0.01% | 877 |
|
|
2023
Q2 | $5.47K | Buy |
26
+23
| +767% | +$4.84K | ﹤0.01% | 708 |
|
|
2023
Q1 | $605 | Hold |
3
| – | – | ﹤0.01% | 887 |
|
|
2022
Q4 | $654 | Sell |
3
-31
| -91% | -$6.76K | ﹤0.01% | 889 |
|
|
2022
Q3 | $7K | Buy |
34
+9
| +36% | +$1.85K | ﹤0.01% | 631 |
|
|
2022
Q2 | $5K | Hold |
25
| – | – | ﹤0.01% | 700 |
|
|
2022
Q1 | $7K | Hold |
25
| – | – | ﹤0.01% | 718 |
|
|
2021
Q4 | $9K | Hold |
25
| – | – | ﹤0.01% | 651 |
|
|
2021
Q3 | $10K | Buy |
+25
| New | +$10K | ﹤0.01% | 619 |
|